Skip to content

Clinical Evaluation of Appropriate Technical Standards for Perioperative Blood Protection in Patients with Cardiovascular Diseases

Clinical Evaluation of Appropriate Technical Standards for Perioperative Blood Protection in Patients with Cardiovascular Diseases

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016561
Enrollment
Unknown
Registered
2018-06-08
Start date
2018-06-08
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases

Interventions

two group:Transfusion threshold based on score group

Sponsors

Department of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged =18 years old; 2. According to the diagnostic criteria reported by the International Society for Cardiovascular Diseases and the World Health Organization, the presence or newly discovered ST segment elevation is more than 1 mm, and the left bundle branch block or pathological Q wave formation continues for at least 10 minutes; 3. troponin increased URL99 percentile; 4. The average place of residence is less than 2500 meters above sea level; 5. To perform cardiac or non-cardiac surgery, perioperative (including preoperative, intraoperative and postoperative) Hb is expected to be less than 10g/dL will enter the screening (a rough estimate can refer to the formula: preoperative Hb (g/dL) - [Estimated blood loss (ml)/400] < 10 g/dL; patients with preoperative Hb less than 10 g/dL can also enter the screening); 6. ASA grade = II grade, NYHA grade = grade II.

Exclusion criteria

Exclusion criteria: 1. emergency bleeding surgery; 2. Patients with hemodynamic instability or other critical conditions, such as ventricular fibrillation, need to be implanted with IABP or ventricular assist device; 3. Clinically diagnosed severe blood system diseases; 4. Clinically diagnosed hemoglobin deficiency in oxygen carrying capacity; 5. High volume hemodilution must be performed; 6. The tumor has been distantly metastasized; 7. For any reason can not cooperate with the study, such as the following: language understanding, mental illness, or participated in other clinical trials; 8. Researchers consider it inappropriate to include this test.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;Arterial oxygen saturation;Mixed venous oxygen saturation;

Countries

China

Contacts

Public ContactHong Zheng

Department of Anesthesiology, The First Affiliated Hospital of Xinjiang Medical University

xjzhenghong@aliyun.com+86 13565996994

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026